- Investing Ideas
- South Korean Pharmaceuticals & Biotech Sustainable Track Record
South Korean Pharmaceuticals & Biotech Sustainable Track Record
Results
6
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
6 companies
PharmaResearch
Market Cap: ₩3.8t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩370,000.00
7D
13.1%
1Y
-32.4%
Samsung BiologicsLtd
Market Cap: ₩71.5t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,545,000.00
7D
14.9%
1Y
-5.8%
Oscotec
Market Cap: ₩1.2t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩31,600.00
7D
3.3%
1Y
-2.8%
JW Shinyak
Market Cap: ₩100.9b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩1,806.00
7D
-10.6%
1Y
16.5%
JW Holdings
Market Cap: ₩266.4b
Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.
A096760
₩3,850.00
7D
2.5%
1Y
7.1%
SK Biopharmaceuticals
Market Cap: ₩6.4t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩81,900.00
7D
6.6%
1Y
-18.3%